Oxidative stress and apoptosis in preeclampsia

Tissue and Cell

Volumn 46, Issue 6, 2014, Pages 477-481

  Can, Murat ^a   Guven, Berrak ^a   Bektas, Sibel ^a   Arikan, Ilker ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

APAF 1; Ki 67; Oxidative stress; Preeclampsia

Indexed keywords

ANTIOXIDANT; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; KI 67 ANTIGEN; MALONALDEHYDE; APAF1 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; TROPHOBLAST; BLOOD; GENETICS; METABOLISM; PATHOLOGY; PREGNANCY;

ADULT; ANTIOXIDANTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CELL PROLIFERATION; FEMALE; HUMANS; KI-67 ANTIGEN; MALONDIALDEHYDE; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84920162424     PISSN: 00408166     EISSN: 15323072     Source Type: Journal    
DOI: 10.1016/j.tice.2014.08.004     Document Type: Article

References (26)

1. Açikgoz S., Harma M., Harma M., Mungan G., Can M., Demirtas S. Comparison of angiotensin-converting enzyme, malonaldehyde, zinc, and copper levels in preeclampsia. Biol. Trace Elem. Res. 2006, 113(1):1-8.
2. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A. Placental apoptosis in preeclampsia. Obstet. Gynecol. 2000, 96(2):271-276.
3. American College of Obstetricians and Gynecologists (ACOG) Criteria practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 2002, 99:159-167.
4. Gulmezoglu A.M., Oosthuizen M.M.J., Hofmeyr G.J. Placental malondialdehyde and glutathione levels in a controlled trial of antioxidant treatment in severe preeclampsia. Hypertens. Pregnancy 1996, 15:287-295.
5. Gupta S., Agarwal A., Sharma R.K. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet. Gynecol. Surviv. 2005, 60:807-816.
6. Herrera B., Alvarez A.M., Sanchez A., Fernandez M., Roncero C., Benito M., Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor b in fetal hepatocytes. FASEB J. 2001, 15:741-751.
7. Hung T.H., Chen S.F., Liou J.D., Hsu J.J., Li M.J., Yeh Y.L., Hsieh T.T. Bax, Bak and mitochondrial oxidants are involved in hypoxia-reoxygenation-induced apoptosis in human placenta. Placenta 2008, 29:565-583.
8. Hung T.H., Chen S.F., Lo L.M., Li M.J., Yeh Y.L., Hsieh T.T. Increased autophagy in placentas of intrauterine growth-restricted pregnancies. PLoS ONE 2012, 7:e40957.
9. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am. J. Obstet. Gynecol. 2002, 186(1):158-166.
10. Ishikawa Y., Kusaka E., Enokido Y., Ikeuchi T., Hatanaka H. Regulation of Bax translocation through phosphorylation at Ser-70 of Bcl-2 by MAP kinase in NO-induced neuronal apoptosis. Mol. Cell. Neurosci. 2003, 24:451-459.
11. Jauniaux E., Poston L., Burton G.J. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum. Reprod. Update 2006, 12:747-755.
12. Kaufmann S.H., Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 2000, 256:42-49.
13. Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 2003, 69:1-7.
14. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin. Chim. Acta 2007, 380:50-58.
15. Mert I., Oruc A.S., Yuksel S., Cakar E.S., Buyukkagnici U., Karaer A., Danisman N. Role of oxidative stress in preeclampsia and intrauterine growth restriction. J. Obstet. Gynaecol. Res. 2012, 38(4):658-664.
16. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S: Cytochrome c release from mitochondria proceeds by a two-step process. Proc. Natl. Acad. Sci. 2002, 99:1259-1263.
17. Ozturk E., Balat O., Acilmis Y.G., Ozcan C., Pence S., Erel Ö. Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J. Obstet. Gynaecol. Res. 2011, 37(4):337-342.
18. Payne C.M., Bernstein C., Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal transduction pathways. Leuk. Lymphoma 1995, 19:43-93.
19. Poranen A.-K., Ekblad U., Uotila P., Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996, 17:401-405.
20. Prusac I.K., Zekic Tomas S., Roje D. Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia. Acta Obstet. Gynecol. Scand. 2011, 90(10):1157-1163.
21. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56.
22. Sharp A.N., Heazell A.E., Crocker I., Mor G. Placental apoptosis in health and disease. Am. J. Reprod. Immunol. 2010, 64:159-169.
23. Tomas S.Z., Prusac I.K., Roje D., Tadin I. Trophoblast apoptosis in placentas from pregnancies complicated by preeclampsia. Gynecol. Obstet. Investig. 2011, 71(4):250-255.
24. Unek G., Ozmen A., Mendilcioglu I., Simsek M., Korgun E.T. The expression of cell cycle related proteins PCNA, Ki67, p27 and p57 in normal and preeclamptic human placentas. Tissue Cell 2014, 46(3):198-205.
25. Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000, 14:1289-1296.
26. Whitley G.S., Dash P.R., Ayling L.J., Prefumo F., Thilaganathan B., Cartwright J.E. Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia. Am. J. Pathol. 2007, 170:1903-1909.